ES8601136A1 - Procedimiento para la obtencion de aminopropanderivados - Google Patents

Procedimiento para la obtencion de aminopropanderivados

Info

Publication number
ES8601136A1
ES8601136A1 ES538161A ES538161A ES8601136A1 ES 8601136 A1 ES8601136 A1 ES 8601136A1 ES 538161 A ES538161 A ES 538161A ES 538161 A ES538161 A ES 538161A ES 8601136 A1 ES8601136 A1 ES 8601136A1
Authority
ES
Spain
Prior art keywords
alkyl
phenyl
hydroxy
contg
opt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES538161A
Other languages
English (en)
Spanish (es)
Other versions
ES538161A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of ES538161A0 publication Critical patent/ES538161A0/es
Publication of ES8601136A1 publication Critical patent/ES8601136A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333Radicals substituted by oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/46Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Machine Translation (AREA)
ES538161A 1983-12-02 1984-11-30 Procedimiento para la obtencion de aminopropanderivados Expired ES8601136A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833343671 DE3343671A1 (de) 1983-12-02 1983-12-02 Aminopropanolderivate von substituierten 2-hydroxy-propiophenonen, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel

Publications (2)

Publication Number Publication Date
ES538161A0 ES538161A0 (es) 1985-11-01
ES8601136A1 true ES8601136A1 (es) 1985-11-01

Family

ID=6215907

Family Applications (1)

Application Number Title Priority Date Filing Date
ES538161A Expired ES8601136A1 (es) 1983-12-02 1984-11-30 Procedimiento para la obtencion de aminopropanderivados

Country Status (14)

Country Link
US (1) US5118685A (enExample)
EP (1) EP0152556B1 (enExample)
JP (1) JPS60136557A (enExample)
AT (1) ATE25083T1 (enExample)
CA (1) CA1233465A (enExample)
CS (1) CS251090B2 (enExample)
DE (2) DE3343671A1 (enExample)
DK (1) DK158979C (enExample)
ES (1) ES8601136A1 (enExample)
FI (1) FI86174C (enExample)
HU (1) HU192625B (enExample)
IL (1) IL73702A (enExample)
NO (1) NO164771C (enExample)
ZA (1) ZA849380B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853408A (en) * 1985-04-23 1989-08-01 Roussel Uclaf 4-phenylpropyl-indoles having antiarythmic activity
FR2584070B1 (fr) * 1985-06-27 1987-08-28 Roussel Uclaf Nouveaux derives de l'hydroxy alkoxy 4-phenyl propyl indole, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant.
FR2624858B1 (fr) * 1987-12-21 1990-06-01 Esteve Labor Dr Nouveaux derives de 2-propanol, leur preparation et leur application en tant que medicaments
DE3825561A1 (de) * 1988-07-28 1990-02-01 Basf Ag P-hydroxiphenon-derivate und diese enthaltende arzneimittel
AT401726B (de) * 1993-05-17 1996-11-25 Gerhard Dr Ecker O-acylaryloxypropanolamine mit tertiärem oder quartärem stickstoff als reversionsmodulatoren für p-glykoprotein mediierte multidrug-resistenz

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA956632A (en) * 1969-05-16 1974-10-22 Yoshitomi Pharmaceutical Industries Phenoxy-aminopropanol derivatives
DE2001431C3 (de) * 1970-01-06 1974-12-12 Helopharm W. Petrik & Co Kg, 1000 Berlin 2-(2'-Hydroxy-3'-alkylaminopropoxy)-Omega-phenyl-propiophenone und Verfahren zur Herstellung derselben
GB1560006A (en) * 1977-08-18 1980-01-30 Laroche Navarron Sa Benzoyl furan derivatives process for their preparation and therapeutic applications thereof
DE2835438A1 (de) * 1978-08-12 1980-03-06 Basf Ag Aminopropanolderivate des 2-(o-hydroxyphenyl)-pyrrols
JPS57188570A (en) * 1981-05-14 1982-11-19 Shionogi & Co Ltd Benzylazole derivative
DE3133814C2 (de) * 1981-08-25 1983-12-22 Helopharm W. Petrik & Co Kg, 1000 Berlin 2-[2'-Hydroxy-3'-(1,1-dimethylpropylamino)-propoxy]-β-phenylpropiophenon, seine Säureadditionssalze und Arzneimittel
DE3226863A1 (de) * 1981-09-18 1983-04-07 Basf Ag, 6700 Ludwigshafen Aminopropanolderivate von 2-hydroxy-ss-phenyl-propiophenonen, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel

Also Published As

Publication number Publication date
FI844729A0 (fi) 1984-11-30
ZA849380B (en) 1985-08-28
EP0152556B1 (de) 1987-01-21
CS251090B2 (en) 1987-06-11
CA1233465A (en) 1988-03-01
US5118685A (en) 1992-06-02
FI844729L (fi) 1985-06-03
NO164771C (no) 1990-11-14
DE3462136D1 (en) 1987-02-26
FI86174B (fi) 1992-04-15
ES538161A0 (es) 1985-11-01
ATE25083T1 (de) 1987-02-15
IL73702A (en) 1988-03-31
JPS60136557A (ja) 1985-07-20
NO844778L (no) 1985-06-03
EP0152556A1 (de) 1985-08-28
IL73702A0 (en) 1985-03-31
JPH0552305B2 (enExample) 1993-08-05
DK158979C (da) 1991-01-07
HU192625B (en) 1987-06-29
FI86174C (fi) 1992-07-27
DK566684A (da) 1985-06-03
DK566684D0 (da) 1984-11-29
HUT36802A (en) 1985-10-28
DE3343671A1 (de) 1985-06-20
NO164771B (no) 1990-08-06
DK158979B (da) 1990-08-13

Similar Documents

Publication Publication Date Title
RU2412192C2 (ru) Сульфонамидтиазолпиридиновые производные как активаторы глюкокиназы, пригодные для лечения диабета типа 2
DK276985D0 (da) Benzofuranderivat og farmaceutisk praeparat indeholdende en saadan forbindelse
ATE196898T1 (de) Aromatische aminoether als schmerzlindernde mittel
EP0176927A3 (en) Diazepine-containing pharmaceutical compositions having a platelet activating factor (paf)-antagonist action
DK436289D0 (da) Cycloalkyl-substituerede glutaramidderivater, farmaceutiske praeparater indeholdende disse forbindelser, forbindelserne til medicinsk anvendelse og deres anvendelse til fremstilling af laegemidler til behandling af hypertension, hjertesvigt eller renal insufficiens
ATE50256T1 (de) Hypoglycemische thiazolidinedione.
PL342608A1 (en) Novel heterocyclic compounds, method of obtaining them, pharmacological compositions containing such compounds and their application in treating diabetes and its associated diseases
DE68913054D1 (de) Verwendung von 4-substituierten-Imidazol-Derivaten in der perioperativen Medikation.
EP0354777A3 (en) 3-(4-piperidine)-5-(2-sulfonylaminoethyl) indole derivatives
ES8801232A1 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxolicas.
RU2005128833A (ru) Замещенные сульфамидами производные ксантина для применения в качестве ингибиторов фосфоенолпируваткарбоксикиназы (рерск)
ES454656A1 (es) Procedimiento para preparar derivados de 4-pirimidona y 4- tiona.
DE69704093D1 (de) Biaryl heterocyclische Verbindungen und ihre Verwendung in der Human- oder Tiermedizin und in der Kosmetik
ES8607263A1 (es) Un procedimiento de preparacion de compuestos heterociclicos
HUT58724A (en) Process for producing heterocyclic carbonyl-propyl-pyrimidinyl-piperazine derivatives and pharmaceutical compositions containing them
ES8602028A1 (es) Procedimiento para la obtencion de derivados del acido meti-lendifosfonico
GB1530413A (en) 5,8-dihydro-5-oxopyrido(2,3-d)pyrimidines
ES2058118T3 (es) Derivados heterociclicos de propeno amida, procedimiento para su preparacion y su uso como farmacos.
NO883776D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
HUT39741A (en) Process for preparing pyridine derivatives and pharmaceutical compositions containing such compounds as active ingredients
ES8103096A1 (es) Un procedimiento para la preparacion de una penicilina.
DE3462136D1 (en) Aminopropanol derivatives of substituted 2-hydroxy-propiophenones, process for their preparation and therapeutic agents containing them
ES445969A1 (es) Un procedimiento de preparacion de la (fluoro-4-trifluorome-tiltio-3-fenil)-1-piperazina.
ZA91118B (en) Indolylpropanols,process for their preparation and their use and preparations containing the compounds
HU678689D0 (en) Process for preparation of new carboximide-amide derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001102